Narrative review / 2022
A review highlights that restoring NAD+ with nicotinamide mononucleotide shows therapeutic potential in age-related chronic conditions.
This review examines the importance of NAD+ in human aging and survival, its biosynthesis, clinical trial findings, and the role of nicotinamide mononucleotide (NMN). Systemic decline in NAD+ is linked to the hallmarks of aging and various age-related disorders. Studies in mice and humans indicate that NMN supplementation offers therapeutic potential for chronic conditions such as diabetes, cardiovascular issues, and cognitive impairment. The authors note that further human interventions are required to investigate the long-term effects of varying NMN doses.
- Study type
- Narrative review
- Who was studied
- Mice and humans
- What was measured
- Aging, NAD+ biosynthesis, diabetes, cardiovascular issues, and cognitive impairment
THE PAPER
The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions.
Soma M, Lalam SK. Mol Biol Rep, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.